Desvenlafaxine recalls
The FDA has published 2 recalls involving Desvenlafaxine since 2014. The latest was reported on 2 Jun 2021. Cardinal Health has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls2since 2014
Last 12 months0reported
Class I00% of total
Ongoing0latest 2 Jun 2021
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why desvenlafaxine is recalled
Companies
Brands
By year
All desvenlafaxine recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Desvenlafaxine Extended-Release Tablets 25 mg recalledDesvenlafaxine | Cardinal Health | Manufacturing (CGMP) Deviations | FL, GA, SC |
| Drug | CLASS II | Pristiq (desvenlafaxine) Extended-Release Tablets 50 mg recalledPristiq | Pfizer Us Pharmaceutical Group | Other | Nationwide |
Should you stop taking Desvenlafaxine?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.